These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
777 related items for PubMed ID: 35287543
41. CircRNA B cell linker regulates cisplatin sensitivity in nonsmall cell lung cancer via microRNA-25-3p/BarH‑like homeobox 2 axis. Liu Y, Hu Y, Zhao C, Lu Q. Anticancer Drugs; 2023 Jun 01; 34(5):640-651. PubMed ID: 36602424 [Abstract] [Full Text] [Related]
42. Exosome-transferred hsa_circ_0014235 promotes DDP chemoresistance and deteriorates the development of non-small cell lung cancer by mediating the miR-520a-5p/CDK4 pathway. Xu X, Tao R, Sun L, Ji X. Cancer Cell Int; 2020 Nov 17; 20(1):552. PubMed ID: 33292236 [Abstract] [Full Text] [Related]
43. Circular RNA hsa_circ_0085131 is involved in cisplatin-resistance of non-small-cell lung cancer cells by regulating autophagy. Kong R. Cell Biol Int; 2020 Sep 17; 44(9):1945-1956. PubMed ID: 32449799 [Abstract] [Full Text] [Related]
44. Exosomal circ_PIP5K1A regulates the progression of non-small cell lung cancer and cisplatin sensitivity by miR-101/ABCC1 axis. Shao N, Song L, Sun X. Mol Cell Biochem; 2021 Jun 17; 476(6):2253-2267. PubMed ID: 33570734 [Abstract] [Full Text] [Related]
45. Hsa_circ_0006677 regulates special AT-rich binding protein-2-mediated tumor-suppressive effect via functioning as a miR-1245a sponge in non-small cell lung cancer. Sui X, Liu Z, Niu L, Yin B, Huo C. Bioengineered; 2022 Feb 17; 13(2):3760-3774. PubMed ID: 35081869 [Abstract] [Full Text] [Related]
46. Circular RNA hsa_circ_0004396 acts as a sponge of miR-615-5p to promote non-small cell lung cancer progression and radioresistance through the upregulation of P21-Activated Kinase 1. Li D, Yan L, Zhang J, Gu F. J Clin Lab Anal; 2022 Jun 17; 36(6):e24463. PubMed ID: 35500159 [Abstract] [Full Text] [Related]
47. Serum Exosomes-Based Biomarker circ_0008928 Regulates Cisplatin Sensitivity, Tumor Progression, and Glycolysis Metabolism by miR-488/HK2 Axis in Cisplatin-Resistant Nonsmall Cell Lung Carcinoma. Shi Q, Ji T, Ma Z, Tan Q, Liang J. Cancer Biother Radiopharm; 2023 Oct 17; 38(8):558-571. PubMed ID: 33661058 [Abstract] [Full Text] [Related]
48. Circ_0011292 knockdown mitigates progression and drug resistance in PTX-resistant non-small-cell lung cancer cells by regulating miR-433-3p/CHEK1 axis. Jin M, Zhang F, Li Q, Xu R, Liu Y, Zhang Y. Thorac Cancer; 2022 May 17; 13(9):1276-1288. PubMed ID: 35348291 [Abstract] [Full Text] [Related]
49. Circular RNA-AnnexinA7 accelerates cisplatin resistance in non-small cell lung cancer via modulating microRNA-545-3p to mediate Cyclin D1. Yao J, Zhang HY, Gu S, Zou JL, Zhang Q, Qu RC. Acta Biochim Pol; 2023 May 23; 70(2):295-304. PubMed ID: 37220402 [Abstract] [Full Text] [Related]
50. Hsa_circ_0092887 targeting miR-490-5p/UBE2T promotes paclitaxel resistance in non-small cell lung cancer. Wang L, Zhang Z, Tian H. J Clin Lab Anal; 2023 Jan 23; 37(1):e24781. PubMed ID: 36550019 [Abstract] [Full Text] [Related]
51. hsa_circ_0003176 Suppresses the Progression of Non-Small-Cell Lung Cancer via Regulating miR-182-5p/RBM5 Axis. Yang F, Pei Y, Xu W, Rong L. Dis Markers; 2022 Jan 23; 2022():8402116. PubMed ID: 36193508 [Abstract] [Full Text] [Related]
52. Circular RNA circ_0003028 contributes to tumorigenesis by regulating GOT2 via miR-1298-5p in non-small cell lung cancer. Guan H, Sun C, Gu Y, Li J, Ji J, Zhu Y. Bioengineered; 2021 Dec 23; 12(1):2326-2340. PubMed ID: 34077306 [Abstract] [Full Text] [Related]
53. Hsa_circ_0003528 promotes cell malignant transformation and immune escape via increasing oncogene PDL1 through sponging miR-511-3p in non-small cell lung cancer. Wang G, Deng L, Gong K, Zhou P, Peng L, Li C. Environ Toxicol; 2023 Jun 23; 38(6):1347-1360. PubMed ID: 36947452 [Abstract] [Full Text] [Related]
54. Circular RNA hsa_circ_0011298 enhances Taxol resistance of non-small cell lung cancer by regulating miR-486-3p/CRABP2 axis. Wu Y, Xie J, Wang H, Hou S, Feng J. J Clin Lab Anal; 2022 May 23; 36(5):e24408. PubMed ID: 35396749 [Abstract] [Full Text] [Related]
55. Circular RNA circ_ASAP2 regulates drug sensitivity and functional behaviors of cisplatin-resistant gastric cancer cells by the miR-330-3p/NT5E axis. Sun Y, Ma J, Lin J, Sun D, Song P, Shi L, Li H, Wang R, Wang Z, Liu S. Anticancer Drugs; 2021 Oct 01; 32(9):950-961. PubMed ID: 34016832 [Abstract] [Full Text] [Related]
56. CircRNA hsa_circ_0075048 promotes the malignant progression of non-small cell lung cancer by up-regulating HMGB2 expression via targeting miR-1225-5p. Zhang J, Mao J. Histol Histopathol; 2023 Jun 01; 38(6):709-724. PubMed ID: 36416408 [Abstract] [Full Text] [Related]
57. Mechanism of METTL14-mediated m6A modification in non-small cell lung cancer cell resistance to cisplatin. Gong S, Wang S, Shao M. J Mol Med (Berl); 2022 Dec 01; 100(12):1771-1785. PubMed ID: 36352154 [Abstract] [Full Text] [Related]
58. circ-LDLRAD3 Knockdown Reduces Cisplatin Chemoresistance and Inhibits the Development of Gastric Cancer with Cisplatin Resistance through miR-588 Enrichment-Mediated SOX5 Inhibition. Liang Q, Chu F, Zhang L, Jiang Y, Li L, Wu H. Gut Liver; 2023 May 15; 17(3):389-403. PubMed ID: 35975639 [Abstract] [Full Text] [Related]
59. Circ-PITX1 promotes non-small-cell lung cancer progression through regulating ETS1 expression via miR-615-5p. Guo Y, Pan J, Gao X, Zheng Y. Thorac Cancer; 2024 Sep 15; 15(27):1946-1957. PubMed ID: 39138880 [Abstract] [Full Text] [Related]
60. The malignant property of circHIPK2 for angiogenesis and chemoresistance in non-small cell lung cancer. Ren M, Song X, Niu J, Tang G, Sun Z, Li Y, Kong F. Exp Cell Res; 2022 Oct 15; 419(2):113276. PubMed ID: 35863454 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]